Form 8-K - Current report:
SEC Accession No. 0001193125-26-262264
Filing Date
2026-06-09
Accepted
2026-06-08 18:23:37
Documents
9
Period of Report
2026-06-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K antx-20260603.htm   iXBRL 8-K 57695
  Complete submission text file 0001193125-26-262264.txt   164225

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT antx-20260603.xsd EX-101.SCH 24884
12 EXTRACTED XBRL INSTANCE DOCUMENT antx-20260603_htm.xml XML 4685
Mailing Address 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA 94025
Business Address 1300 EL CAMINO REAL, SUITE 100 MENLO PARK CA 94025 (650) 331-9090
AN2 Therapeutics, Inc. (Filer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41331 | Film No.: 261073917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)